At Stoic, we know that breakthrough innovation is found in all domains of research. We come in early, looking to partner with founders at early TRL levels.
We write first cheques between $100k to $500k.
Our mission is to bring catalytic technologies to market, to solve what was previously unsolvable.
Tracking TRLs over time is one way we visualise value creation and retiring technical risk as investors.
We believe that having a strong conviction, immersion and patience is more valuable than any accreditation.
Our founding partners have decades of experience raising capital and investing in companies from therapeutics to satellite technologies.
In 2019 we were founded on a partnership with Uniseed – Australia’s longest standing venture fund.
Since then, we’ve built a proprietary funnel & network of Investors, Operators and Academics who have lived through it all.
Whenever you’ve got a question, we’ve got the right people ready to chat.
Building the future through novel therapies, medical devices and deep engineering, take time. We’re willing to stay the course.
We’re lean but locked in. We’re proud of our efficiency and ambitious of our partnerships.
We leverage our unique DNA from diverse backgrounds to help you from lab-to-market.
investments
exits
female founders
sectors
Having investors like Stoic with expertise that complements or fills gaps, as well as a genuine interest and shared passion for helping achieving outcomes, has been rewarding for everyone involved and contributed to our growth
Geoff has been greatly supportive and generous with his time. From new connections that have allowed us to grow, to unbiased opinion & guidance whenever I need it most. We are lucky to have Geoff on the journey.
